Paper Title
A REVIEW: PARALYSIS IT’S TYPES,CAUSES, SYMPTOMS AND ANTIPARALYTIC MEDICINES USED
Article Identifiers
Keywords
Paralysis, Types, Causes and Symptoms, Diagnosis and Complications, Anti-Paralytic plants, 37 medicinal plants, Review
Abstract
Paralysis is a temporary or permanent loss of voluntary muscle movement. A nervous system problem causes paralysis. Due to disturbance of waving between the nervous system and muscles. People can occurrence localized, generalized partial or complete paralysis. Nearly all common causes of paralysis is Spinal Cord Injury (SCI), Head Injury, Peripheral neuropathy, stroke and multiple sclerosis. Bell’s Palsy causes temporary facial paralysis. Not primarily, muscles themselves are the cause, as this could also be due to a problem around somewhere along the chain of nerve cells that travel from the body part to your brain and back again. In this review, gain an understanding more about the types of paralysis, their causes, symptoms, complications, diagnosis and the most important 37 medicinal plant for their application and cure of sickness related to paralysis. Out of the 37 plants documented, 11 plants have been reported for their ability to cure paralysis. Although, the information on the recorded plants were mainly found to be deficient, requiring proper authentication with respect to their specificity, dosage, contra-indication etc. It is belived that with huge intervention on analysis of bioactive compounds present in these plants used by ethic traditional healers for paralysis.
Downloads
How To Cite (APA)
Mrs. Aishwarya Prashant Pimple, Miss. Priyanka Yuvraj Padle, & Dr. Gajanan S Sanap (February-2022). A REVIEW: PARALYSIS IT’S TYPES,CAUSES, SYMPTOMS AND ANTIPARALYTIC MEDICINES USED. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 7(2), 168-180. https://ijnrd.org/papers/IJNRD2202025.pdf
Issue
Volume 7 Issue 2, February-2022
Pages : 168-180
Other Publication Details
Paper Reg. ID: IJNRD_180497
Published Paper Id: IJNRD2202025
Downloads: 000122254
Research Area: Pharmacy
Author Type: Indian Author
Country: Aurangabad, Maharashtra, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2202025.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2202025
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.
For more details, refer to the official notice: UGC Public Notice
Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: December 2025
Current Issue: Volume 10 | Issue 12 | December 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Dec-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
Approval, Licenses and Indexing: More Details
:
